Anticoagulation of juvenile sheep and goats with heparin, warfarin, and clopidogrel

ASAIO Journal

Volumn 53, Issue 2, 2007, Pages 229-237

  Connell, John M ^a,b   Khalapyan, Tigran ^a   Al Mondhiry, Hamid A ^a   Wilson, Ronald P ^a   Rosenberg, Gerson ^a   Weiss, William J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b Division of Artificial Organs H 151   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BLOOD; DRUG PRODUCTS; PEDIATRICS;

ANTICOAGULATION; CLOPIDOGREL; HEPARIN; WARFARIN;

BIOMEDICAL ENGINEERING;

CLOPIDOGREL; HEPARIN; WARFARIN;

ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING TIME; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; GOAT; INTERNATIONAL NORMALIZED RATIO; LOADING DRUG DOSE; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; SHEEP; THROMBOELASTOGRAPHY;

AGE FACTORS; ANIMALS; ANTICOAGULANTS; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GOATS; HEPARIN; MALE; PARTIAL THROMBOPLASTIN TIME; PLATELET AGGREGATION; PROTHROMBIN TIME; SHEEP; THROMBELASTOGRAPHY; TICLOPIDINE; WARFARIN; WHOLE BLOOD COAGULATION TIME;

EID: 34247152537     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e31802e192b     Document Type: Article

References (49)

1. Guyton A, Hall J: Textbook of Medical Physiology. Philadelphia, Saunders, 2000.
2. Lawrence C, Prinzen F, De Lange S: Hemodynamic and coronary vascular effects of demedetomidine in the anesthetized goat. Acta Anaesthesiol Scand 41: 830-836, 1997.
3. Stowe C, Good A: Estimation of cardiac output in calves and sheep by the dye and Fick oxygen techniques. Am J Physiol 198: 987-990, 1960.
4. Vinas M: Extracorporeal circulation, in Cardiac Anesthesia for Infants and Children, St. Louis, C.V. Mosby, 1994.
5. Petz L, Swisher N, Kleinman S, et al: Clinical Practice of Transfusion Medicine. New York, Churchill-Livingstone, 1996.
6. Esmore D, Kaye D, Salamonsen R, et al: First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure. J Heart Lung Transplant 24: 1150-1154, 2005.
7. Nakamura T, Hayashi K, Seki J: Chronic effects of a cardiac assist device on the bulk and regional mechanics of the failed left ventricle in goats. Artif Organs 17: 350-361, 1993.
8. Nakatani T, Anai H, Goto M, et al: An abdominally placed, implantable left ventricular assist system for long-term use. ASAIO J 38: M631-633, 1992.
9. Nojiir C, Kijima T, Maekawa, et al: Terumo implantable left ventricular assist system: Results of a long-term animal study. ASAIO J 46: 117-122, 2000.
10. National Research Council: Guide for the Care and Use of Laboratory Animals. NIH Publication No. 86-23. Washington DC, Public Health Service, 1986.
11. Gajewski J, Povar M: Blood coagulation values of sheep. Am J Vet Res 405-409, 1971.
12. Greene CE, Tsang VC, Prestwood AK, Meriwether EA: Coagulation studies of plasmas from healthy domesticated animals and persons. Am J Vet Res 42: 2170-2177, 1981.
13. Moalic P, Gruel Y, Foloppe P, et al: Hemostasis development in the lamb fetus and neonate. Am J Vet Res 50: 59-63, 1989.
14. Wakabayashi A, Chen CC, Mullin PJ, Connolly JE: Successful prolonged heparinless venoarterial bypass in sheep. J Thorac Cardiovasc Surg 71: 648-658, 1976.
15. Hirsh J, Poller L: International normalized ratio: A guide to understanding and correcting its problems. Arch Intern Med 154: 282-288, 1994.
16. Podczasy J, Lee J, Vucenik I: Evaluation of whole-blood lumiaggregation. Clin Appl Thromb Hemost 3: 190-195, 1997.
17. Soloviev M, Okazaki Y, Harasaki H, et al: Whole blood platelet aggregation in humans and animals: A comparative study. J Surg Res 82: 180-187, 1999.
18. Stewart M: Heparin-induced thrombocytopenia: An improved method of detection based on lumiaggregometry. Br J Haematol 91: 173-177, 1995.
19. Vucenik I, Podczasy J: Whole blood lumiaggregation: Evaluation of reagents. Clin Appl Thromb Hemost 4: 253-256, 1998.
20. Pelagalli A, Lombardi P, d'Angelo D, et al: Species variability in platelet aggregation response to different agonists. J Comp Pathol 127: 126-132, 2002.
21. Chrono-log Corporation: Chrono-log whole blood lumiaggregometer protocol. Version 5.1. February 10, 2004.
22. Frazier O: Implantation of the Jarvik 2000 left ventricular assist device without the use of cardiopulmonary bypass. Ann Thorac Surg 75: 1028-1030, 2003.
23. Gravlee G, Davis RF, Utley JR: Cardiopulmonary Bypass: Principles and Practice. Baltimore, Williams and Wilkins, 2000.
24. De Waele JJ, Van Cauwenberghe S, Hoste E, et al: The use of the activated clotting time for monitoring heparin therapy in critically ill patients. Intensive Care Med 29: 325-328, 2003.
25. Stiller B, Lemmer J, Merkle F, et al: Consumption of blood products during mechanical circulatory support in children: comparison between ECMO and a pulsatile ventricular assist device. Intensive Care Med 30: 1814-1820, 2004.
26. Morag M, Smith D: The effect of two synthetic anticoagulant drugs (Coumarin and Indandione) in the ewe. Res Vet Sci 12: 106-112, 1971.
27. Bristol Myers Squibb: Plavix, prescribing information. Available at: http://products.sanofi-aventis.us/plavix/plavix.html. Accessed October 6, 2006.
28. Savcic M, Hauert J, Bachmann F, et al: Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost 25: S15-19, 1999.
29. Schror K: Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel. Vasc Med 3: 247-251, 1998.
30. Thebault J, Kieffer G, Lowe G, et al: Repeated-dose pharmacodynamics of clopidogrel in healthy subjects. Semin Thromb Hemost 25: 1999.
31. Eikelboom J, Hankey G, Thom J, et al: Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: A randomized crossover trial. J Thromb Haemost 3: 2649-2655, 2005.
32. Weber A, Hohlfeld T, Schror K: ADP-induced second wave aggregation in platelet rich plasma from hypercholesterolemic rabbits. Thromb Res 64: 703-712, 1991.
33. Boneu B, Destelle G: Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients. Thromb Haemost 76: 939-943, 1996.
34. Roald HE, Barstad RM, Kierulf P, et al: Clopidogrel: A platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions. Thromb Haemost 71: 655-662, 1994.
35. Borna C, Lazarowski E, van Heusden C, et al: Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J 3: 10, 2005.
36. Taka T, Okano E, Seki J, et al: Effects of clopidogrel on platelet activation and coagulation of non-anticoagulated rat blood under high shear stress. Haemostasis 29: 189-196, 1999.
37. Turner NA, Moake JL, McIntire LV: Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow. Blood 98: 3340-3345, 2001.
38. Orford JL, Kinlay S, Adams MR, et al: Clopidogrel inhibits shear-induced platelet function. Platelets 13: 187-189, 2002.
39. Chow G, Kini RM: Exogenous factors from animal sources that induce platelet aggregation. Thromb Haemost 85: 177-178, 2001.
40. Gupta PK, Kannan M, Chatterjee T, et al: Acquired von Willebrand's disease associated with gastrointestinal angiodysplasia: A case report. Haemophilia 12: 452-455, 2006.
41. Andrew M, Paes B, Johnston M: Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hem Oncol 12: 95-104, 1990.
42. Mitruka BM, Rawnsley HM: Clinical and Hematological Reference Values in Normal Experimental Animals and Normal Humans. New York, Masson Publishing, 1981.
43. Miller DR: Normal blood values from birth through adolescence, in Blood Diseases of Infancy and Childhood: In the Tradition of Carl H. Smith, St. Louis, Mosby, 1995.
44. Jain NC: Schalm's Veterinary Hematology. Philadelphia, Lea & Febiger, 1986.
45. Tillman P, Carson SN, Talken L: Platelet function and coagulation parameters in sheep during experimental vascular surgery. Lab Anim Sci 31: 263-267, 1981.
46. Gross DR, Kramer WG, McCord F, Wagner-Mann C: Pharmacodynamics and pharmacokinetics of orally administered bishydroxycoumarin in the goat. Am J Vet Res 47: 2053-2056, 1986.
47. Smith MC: Goat Medicine. Philadelphia, Lea & Febiger, 1994.
48. International Technidyne Corp: HEMOCHRON Response Whole Blood Coagulation System FTCA510 [package insert, HM0459]. Edison, NJ, International Technidyne, 2003.
49. Lee BY, Taha S, Trainor FS, et al: Monitoring heparin therapy with thromboelastography and activated partial thromboplastin time. World J Surg 4: 323-330, 1980.